Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher tous les synonymes
Sélectionnez vos espèces d'intérêt
Human ACPP Protein expressed in Human - ABIN935721
Drake, White, Fuller, Igwe, Clements, Nyalwidhe, Given, Lance, Semmes: Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease. dans Journal of proteomics 2009
Enhanced TDPase and TMPase activities may contribute to the reduction of TDP level in AD patients. The results imply that an imbalance of phosphorylation-dephosphorylation related to thiamine and glucose metabolism may be a potential target for AD prevention and therapy.
Thirteen single nucleotide polymorphism (SNPs) in acid phosphatase prostate (ACPP) were suggested as candidate causal alleles that underlie ACPP regulation and expression.
we have measured the intramolecular diffusion of the full length and 8-residue deletion peptides at two different pHs (Montrer PCBD1 Protéines) and found a correlation with fibrillization lag (Montrer STMN1 Protéines) time. These results can be explained by a simple kinetic model of the early stages of aggregation in which oligomerization is controlled by the rate of peptide reconfiguration.
Prostatic acid phosphatase delays prostate cancer cell growth in G1 phase of the cell cycle.
Studies suggest that understanding of prostatic acid phosphatase function and regulation of expression will have a significant impact on understanding prostate cancer (PCa (Montrer FLVCR1 Protéines)) progression and therapy.
Certain factors identified within semen, termed semen-derived enhancers of virus infection (SEVI), fragments of prostatic acid phosphatase, have been shown to significantly enhance HIV-1 infectivity.
ACPP increases significantly in epithelial cells of ovarian carcinoma, which indicates that it may be a candidate biomarker for diagnosis of epithelia-derived ovarian cancer in women.
Data indicate that hypoxia regulates prostatic acid phosphatase (PAP) through hypoxia-inducible factor 2 alpha (Montrer EPAS1 Protéines) (HIF2alpha (Montrer EPAS1 Protéines)) and from stimulated A2B (Montrer ADORA2B Protéines) adenosine receptors.
GCNT1 (Montrer GCNT1 Protéines) is over-expressed in prostate cancer and is associated with higher levels of core 2 O-sLe(x) in PSA (Montrer PLAG1 Protéines), PAP (Montrer REG3A Protéines) and MUC1 (Montrer MUC1 Protéines) proteins.
Data indicate that prostate acid phosphatase-based peptide vaccine PAP (Montrer REG3A Protéines)-114-128 peptide appears to be a relevant for the treatment of prostate cancer.
PAP (Montrer ASAP1 Protéines)-immunoreactivity was present in type I and one of type III taste cells of taste buds. Thus, it is suggested that PAP (Montrer ASAP1 Protéines) might be a responsible ectoenzyme for metabolism of extracellular nucleotides, being involved in the regulation of taste signaling in taste buds.
These findings demonstrate that PAP (Montrer ASAP1 Protéines) secreted by PCa (Montrer ENPP1 Protéines) cells in OB bone metastases increases osteoprotegerin (Montrer TNFRSF11B Protéines) and plays a critical role in the vicious cross talk between cancer and bone cells.
functional PAP (Montrer ASAP1 Protéines)(thorn) neurons are essential for the analgesic effect, which is mediated by NGF (Montrer NGFB Protéines)-trkA (Montrer NTRK1 Protéines) signaling.
TMPAP is involved in the control of GABAergic tone in the brain also through exocytosis, and that PAP (Montrer ASAP1 Protéines) deficiency produces a distinct neurological phenotype.
In male mouse saliva (Montrer RAG1AP1 Protéines) prostatic acid phosphatase regulates salivation.
Data indicate that prostate acid phosphatase-based peptide vaccine PAP (Montrer ASAP1 Protéines)-114-128 peptide appears to be a relevant for the treatment of prostate cancer.
this PAP (Montrer ASAP1 Protéines)-/- mouse model shows that TMPAP is required for the normal function of prostate in mice, and its deficiency leads to prostate adenocarcinoma.
Both prostatic acid phosphatase and ecto-5'-nucleotidase generate adenosine in the dorsal spinal cord.
Prostatic acid phosphatase is required for the antinociceptive effects of thiamine and benfotiamine.
Experiments indicate that PAP (Montrer ASAP1 Protéines) and NT5E (Montrer NT5E Protéines) are the main ectonucleotidases that generate adenosine in nociceptive circuits and indicate these enzymes transform pulsatile or sustained nucleotide release into an inhibitory adenosinergic signal.
The obtained N-terminal amino-acid sequence of boar PTAP showed 92% identity with the N-terminal amino-acid sequence of human PAP (Montrer PDAP1 Protéines). The determined sequence of a 354 bp nucleotide fragment showed 90% identity with the corresponding sequence of human PAP (Montrer PDAP1 Protéines).
This gene encodes a multidomain protein containing an N-terminal alpha-helical region with a coiled-coil motif, followed by a pleckstrin homology (PH) domain, an Arf-GAP domain, an ankyrin homology region, a proline-rich region, and a C-terminal Src homology 3 (SH3) domain. The protein localizes in the Golgi apparatus and at the plasma membrane, where it colocalizes with protein tyrosine kinase 2-beta (PYK2). The encoded protein forms a stable complex with PYK2 in vivo. This interaction appears to be mediated by binding of its SH3 domain to the C-terminal proline-rich domain of PYK2. The encoded protein is tyrosine phosphorylated by activated PYK2. It has catalytic activity for class I and II ArfGAPs in vitro, and can bind the class III Arf ARF6 without immediate GAP activity. The encoded protein is believed to function as an ARF GAP that controls ARF-mediated vesicle budding when recruited to Golgi membranes. In addition, it functions as a substrate and downstream target for PYK2 and SRC, a pathway that may be involved in the regulation of vesicular transport. Multiple transcript variants encoding different isoforms have been found for this gene.
, prostatic acid phosphatase
, prostatic acid phosphotase
, thiamine monophosphatase
, PYK2 C terminus-associated protein
, arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2
, centaurin, beta 3
, development and differentiation enhancing factor 2
, development and differentiation-enhancing factor 2
, paxillin-associated protein with ARF GAP activity 3
, pyk2 C-terminus-associated protein
, fluoride-resistant acid phosphatase
, lysosomal acid phosphatase
, prostatic acid phosphatase (rPAP)
, acid phosphatase, prostate
, tyrosine acid phosphatase
, prostatic acid phosphatase-like
, testicular acid phosphatase homolog